Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$517M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$516M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$296M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$441M |
| 2 |
Duke Energy
DUK
|
+$407M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.71% |
| 2 | Financials | 4.45% |
| 3 | Healthcare | 3.9% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDR
3926
DELISTED
Alder Biopharmaceuticals
ALDR
| $262K | ﹤0.01% |
12,557
+9,755
| +348% | +$254K |
|
|
CYS
3927
DELISTED
CYS Investments Inc.
CYS
| $262K | ﹤0.01% |
33,986
+30,643
| +917% | +$250K |
|
3928
iShares MSCI Australia ETF
EWA
$1.45B
| $260K | ﹤0.01% |
12,847
-29,533
| -70% | -$608K |
|
3929
CALL
Silicon Laboratories
SLAB
$7.23B
| $260K | ﹤0.01% |
4,000
-4,500
| -53% | -$283K |
|
|
DBD
3930
DELISTED
Diebold Nixdorf Incorporated
DBD
| $260K | ﹤0.01% |
10,336
+7,509
| +266% | +$177K |
|
|
MTOR
3931
CALL
DELISTED
MERITOR, Inc.
MTOR
| $260K | ﹤0.01% |
20,900
+20,400
| +4,080% | +$240K |
|
|
CBL
3932
DELISTED
CBL& Associates Properties, Inc.
CBL
| $260K | ﹤0.01% |
22,692
+1,976
| +10% | +$22.9K |
|
3933
PUT
Lazard
LAZ
$4.31B
| $259K | ﹤0.01% |
6,300
-6,300
| -50% | -$245K |
|
3934
PUT
Teekay
TK
$985M
| $259K | ﹤0.01% |
32,300
+10,100
| +45% | +$77.8K |
|
|
CEB
3935
DELISTED
CEB Inc.
CEB
| $259K | ﹤0.01% |
4,272
+2,090
| +96% | +$115K |
|
|
AFCO
3936
DELISTED
American Farmland Company
AFCO
| $259K | ﹤0.01% |
32,500
+5,011
| +18% | +$37.7K |
|
3937
Collegium Pharmaceutical
COLL
$956M
| $258K | ﹤0.01% |
16,607
+5,299
| +47% | +$88.1K |
|
3938
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$531M
| $258K | ﹤0.01% |
+231
| New | +$410K |
|
3939
CALL
Sturm, Ruger & Co
RGR
$593M
| $258K | ﹤0.01% |
4,900
-12,000
| -71% | -$663K |
|
|
NTRI
3940
DELISTED
NutriSystem, Inc.
NTRI
| $258K | ﹤0.01% |
7,449
+2,054
| +38% | +$69.4K |
|
3941
PENN Entertainment
PENN
$2.71B
| $257K | ﹤0.01% |
18,581
-82,720
| -82% | -$1.13M |
|
3942
CALL
Sanmina
SANM
$10.9B
| $257K | ﹤0.01% |
7,000
+6,800
| +3,400% | +$215K |
|
|
KYNB
3943
Kyntra Bio
KYNB
$29.4M
| $256K | ﹤0.01% |
480
+407
| +558% | +$203K |
|
|
KNDI
3944
CALL
Kandi Technologies Group
KNDI
$65.5M
| $255K | ﹤0.01% |
52,000
+27,700
| +114% | +$137K |
|
3945
CALL
Moody's
MCO
$82.7B
| $255K | ﹤0.01% |
2,700
+2,500
| +1,250% | +$252K |
|
3946
PUT
Pitney Bowes
PBI
$2.39B
| $255K | ﹤0.01% |
16,800
-900
| -5% | -$14.3K |
|
3947
UMB Financial
UMBF
$11.1B
| $254K | ﹤0.01% |
3,286
+2,256
| +219% | +$157K |
|
|
CEMP
3948
PUT
DELISTED
Cempra, Inc.
CEMP
| $254K | ﹤0.01% |
+90,900
| New | +$1.1M |
|
3949
PUT
Coty
COTY
$2.48B
| $253K | ﹤0.01% |
13,800
-1,059,700
| -99% | -$21.9M |
|
3950
CALL
UGI
UGI
$7.33B
| $253K | ﹤0.01% |
5,500
+5,100
| +1,275% | +$228K |
|
Similar funds
Barclays's Q4 2016 Portfolio in Review
As of Q4 2016, Barclays held 7,178 positions worth $92.5B, up 2.7% from $90.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays's Q4 2016 filing shows 490 new, 3,383 increased, 2,405 reduced and 438 closed positions. Its largest new stake was Howmet Aerospace: 1,639,920 shares worth $23.3M. The largest sale was Procter & Gamble, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q4 2016 buy was Howmet Aerospace: 1,639,920 shares worth $23.3M.
- Barclays added most to State Street Technology Select Sector SPDR ETF in Q4 2016, an estimated $517M increase.
- Barclays's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $441M.
- Barclays fully exited LinkedIn Corporation in Q4 2016, selling an estimated $223M.
- Barclays's ten largest holdings make up 34% of its $92.5B portfolio in Q4 2016.
- Barclays opened 490 new positions and closed 438 in Q4 2016.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $92.5B.
Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.